Cargando…
Genetic screening for single-cell variability modulators driving therapy resistance
Cellular plasticity describes cells’ ability to transition from one set of phenotypes to another. In melanoma, transient fluctuations in the molecular state of tumor cells mark the formation of rare cells primed to survive BRAF inhibition and reprogram into a stably drug resistant fate. However, the...
Autores principales: | Torre, Eduardo A., Arai, Eri, Bayatpour, Sareh, Jiang, Connie L., Beck, Lauren E., Emert, Benjamin L., Shaffer, Sydney M., Mellis, Ian A., Fane, Mitchell E., Alicea, Gretchen M., Budinich, Krista A., Weeraratna, Ashani T., Shi, Junwei, Raj, Arjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796998/ https://www.ncbi.nlm.nih.gov/pubmed/33398196 http://dx.doi.org/10.1038/s41588-020-00749-z |
Ejemplares similares
-
Disrupting cellular memory to overcome drug resistance
por: Harmange, Guillaume, et al.
Publicado: (2023) -
ClampFISH detects individual nucleic-acid molecules using click chemistry based amplification
por: Rouhanifard, Sara H., et al.
Publicado: (2018) -
Variability within rare cell states enables multiple paths towards drug resistance
por: Emert, Benjamin L., et al.
Publicado: (2021) -
A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis
por: Marino, Gloria E., et al.
Publicado: (2020) -
Autophagy- An emerging target for melanoma therapy
por: Ndoye, Abibatou, et al.
Publicado: (2016)